Identification of Respiratory Syncytial Virus Nonstructural Protein 2 Residues Essential for Exploitation of the Host Ubiquitin System and Inhibition of Innate Immune Responses

Journal of Virology

Volumn 90, Issue 14, 2016, Pages 6453-6463

  Whelan, Jillian N ^a   Tran, Kim C ^a   van Rossum, Damian B ^b   Tenga, Michael N ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 2; STAT2 PROTEIN; UBIQUITIN; NS2 PROTEIN, HUMAN RESPIRATORY SYNCYTIAL VIRUS; VIRAL PROTEIN;

ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVERSE GENETICS; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS RECOMBINANT; VIRUS REPLICATION; A-549 CELL LINE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CHLOROCEBUS AETHIOPS; GENETICS; IMMUNOLOGY; METABOLISM; MUTATION; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS; VERO CELL LINE; VIROLOGY; VIRUS LOAD;

A549 CELLS; AMINO ACID SEQUENCE; ANIMALS; CERCOPITHECUS AETHIOPS; HUMANS; IMMUNITY, INNATE; MUTAGENESIS, SITE-DIRECTED; MUTATION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; STAT2 TRANSCRIPTION FACTOR; UBIQUITIN; UBIQUITINATION; VERO CELLS; VIRAL LOAD; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 84977598318     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00423-16     Document Type: Article

References (40)

1. Collins LP, Chanock Robert M, Murphy Brian R. 2001. Respiratory syncytial virus. Lippincott Williams and Wilkins, Philadelphia, PA.
2. Teng MN. 2012. The non-structural proteins of RSV: targeting interferon antagonists for vaccine development. Infect Disord Drug Targets 12:129- 137. http://dx.doi.org/10.2174/187152612800100170.
3. Spann KM, Tran KC, Chi B, Rabin RL, Collins PL. 2004. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J Virol 78:4363-4369. http://dx.doi.org/10 .1128/JVI.78.8.4363-4369.2004.
4. Fontana JM, Bankamp B, Rota PA. 2008. Inhibition of interferon induction and signaling by paramyxoviruses. Immunol Rev 225:46-67. http: //dx.doi.org/10.1111/j.1600-065X.2008.00669.x.
5. Lo MS, Brazas RM, Holtzman MJ. 2005. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol 79:9315-9319. http: //dx.doi.org/10.1128/JVI.79.14.9315-9319.2005.
6. Ramaswamy M, Shi L, Varga SM, Barik S, Behlke MA, Look DC. 2006.Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 344:328-339. http://dx.doi .org/10.1016/j.virol.2005.09.009.
7. Ling Z, Tran KC, Teng MN. 2009. Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J Virol 83:3734-3742. http://dx .doi.org/10.1128/JVI.02434-08.
8. Swedan S, Musiyenko A, Barik S. 2009. Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways. J Virol 83:9682-9693. http://dx.doi.org/10.1128/JVI .00715-09.
9. Elliott J, Lynch OT, Suessmuth Y, Qian P, Boyd CR, Burrows JF, Buick R, Stevenson NJ, Touzelet O, Gadina M, Power UF, Johnston JA. 2007. Respiratory syncytial virus NS1 protein degrades STAT2 by using te elongin-cullin E3 ligase. J Virol 81:3428-3436. http://dx.doi.org/10.1128 /JVI.02303-06.
10. Hochstrasser M. 1996. Ubiquitin-dependent protein degradation. Annu Rev Genet 30:405-439. http://dx.doi.org/10.1146/annurev.genet.30.1.405.
11. Jiang X, Chen ZJ. 2012. The role of ubiquitylation in immune defence and pathogen evasion. Nat Rev Immunol 12:35-48. http://dx.doi.org/10.1038 /nri3111.
12. Clague MJ, Urbe S. 2010. Ubiquitin: same molecule, different degradation pathways. Cell 143:682-685. http://dx.doi.org/10.1016/j.cell.2010.11 .012.
13. Schnell JD, Hicke L. 2003. Non-traditional functions of ubiquitin and ubiquitin-binding proteins. J Biol Chem 278:35857-35860. http://dx.doi .org/10.1074/jbc.R300018200.
14. Zimmerman ES, Schulman BA, Zheng N. 2010. Structural assembly of cullin-RING ubiquitin ligase complexes. Curr Opin Struct Biol 20:714- 721. http://dx.doi.org/10.1016/j.sbi.2010.08.010.
15. Dikic I, Wakatsuki S, Walters KJ. 2009. Ubiquitin-binding domains- from structures to functions. Nat Rev Mol Cell Biol 10:659-671. http://dx .doi.org/10.1038/nrm2767.
16. Gustin JK, Moses AV, Fruh K, Douglas JL. 2011. Viral takeover of the host ubiquitin system. Front Microbiol 2:161. http://dx.doi.org/10.3389 /fmicb.2011.00161.
17. Wang YE, Park A, Lake M, Pentecost M, Torres B, Yun TE, Wolf MC, Holbrook MR, Freiberg AN, Lee B. 2010. Ubiquitin-regulated nuclearcytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding. PLoS Pathog 6:e1001186. http://dx.doi.org/10.1371 /journal.ppat.1001186.
18. Liao TL, Wu CY, Su WC, Jeng KS, Lai MM. 2010. Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication. EMBO J 29:3879-3890. http://dx.doi.org/10.1038/emboj.2010.250.
19. Yokota S, Okabayashi T, Yokosawa N, Fujii N. 2008. Measles virus P protein suppresses Toll-like receptor signal through up-regulation of ubiquitin-modifying enzyme A20. FASEB J 22:74-83.
20. Okumura A, Alce T, Lubyova B, Ezelle H, Strebel K, Pitha PM. 2008. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 373:85-97. http://dx.doi.org/10 .1016/j.virol.2007.10.042.
21. Ulane CM, Horvath CM. 2002. Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 304:160-166. http://dx.doi.org/10.1006/viro.2002.1773.
22. Ling Z, Tran KC, Arnold JJ, Teng MN. 2008. Purification and characterization of recombinant human respiratory syncytial virus nonstructural protein NS1. Protein Expr Purif 57:261-270. http://dx.doi.org/10 .1016/j.pep.2007.09.017.
23. Beeler JA, Coelingh KV. 1989. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function. J Virol 63:2941-2950.
24. Chintapalli SV, Bhardwaj G, Patel R, Shah N, Patterson RL, van Rossum DB, Anishkin A, Adams SH. 2015. Molecular dynamic simulations reveal the structural determinants of fatty acid binding to oxymyoglobin. PLoS One 10:e0128496. http://dx.doi.org/10.1371/journal .pone.0128496.
25. Hedgepeth SC, Garcia MI, Wagner LE, II, Rodriguez AM, Chintapalli SV, Snyder RR, Hankins GD, Henderson BR, Brodie KM, Yule DI, van Rossum DB, Boehning D. 2015. The BRCA1 tumor suppressor binds to inositol 1,4,5-trisphosphate receptors to stimulate apoptotic calcium release. J Biol Chem 290:7304-7313. http://dx.doi.org/10.1074/jbc.M114 .611186.
26. Hong YCS, Bhardwaj G, Zhang Z, Patterson RL, van Rossum DB. 2011. Adaptive-BLAST: a user-defined platform for the study of proteins. J Integr Omics 1:88-101.
27. Ko K, Liu C, Rwebangira MR, Burge L, Southerland W. 2011. The development of a proteomic analyzing pipeline to identify proteins with multiple RRMs and predict their domain boundaries, p 374-381. In Chen B, Chen J, Chen X, Chen Y, Cho Y-R, Cui J, Haspel N, He J, Hsu H-H, Huang Y, Huang K, Jiang R, Khudyakov Y, Kwo CK, Li G, Li G-Z, Mandoiu I, Park T, Policriti A, Qin ZS, Reddy C, Ressom H, Satten G, Schonback C, Shehu A, Song M, Song X, Tseng V, Xiong Z, Yoo I, Zelikovsky A, Zhang G, Zhang J, Zho S, Zhao Z, Zheng J, Zhu D (ed), Proceedings of the 2011 IEEE International Conference on Bioinformatics and Biomedicine Workshops, Atlanta, GA. Institute of Electrical and Electronics Engineers, New York, NY.
28. Teng MN, Whitehead SS, Collins PL. 2001. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membranebound forms to virus replication in vitro and in vivo. Virology 289:283- 296. http://dx.doi.org/10.1006/viro.2001.1138.
29. Teng MN, Whitehead SS, Bermingham A, St Claire M, Elkins WR, Murphy BR, Collins PL. 2000. Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees. J Virol 74:9317-9321. http://dx.doi.org/10 .1128/JVI.74.19.9317-9321.2000.
30. Teng MN, Collins PL. 1999. Altered growth characteristics of recombi- nant respiratory syncytial viruses which do not produce NS2 protein. J Virol 73:466-473.
31. Spann KM, Collins PL, Teng MN. 2003. Genetic recombination during coinfection of two mutants of human respiratory syncytial virus. J Virol 77:11201-11211. http://dx.doi.org/10.1128/JVI.77.20.11201-11211.2003.
32. Collins PL, Hill MG, Camargo E, Grosfeld H, Chanock RM, Murphy BR. 1995. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5= proximal open reading frame of theM2mRNAin gene expression and provides a capability for vaccine development. Proc Natl Acad Sci U S A 92:11563-11567. http://dx.doi.org/10.1073/pnas.92 .25.11563.
33. Hotard AL, Shaikh FY, Lee S, Yan D, Teng MN, Plemper RK, Crowe JE, Jr, Moore ML. 2012. A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis. Virology 434:129-136. http://dx.doi.org/10.1016/j.virol.2012.09.022.
34. Pastey MK, Samal SK. 1995. Nucleotide sequence analysis of the nonstructural NS1 (1C) and NS2 (1B) protein genes of bovine respiratory syncytial virus. J Gen Virol 76:193-197. http://dx.doi.org/10.1099/0022 -1317-76-1-193.
35. Sacco RE, Durbin RK, Durbin JE. 2015. Animal models of respiratory syncytial virus infection and disease. Curr Opin Virol 13:117-122. http: //dx.doi.org/10.1016/j.coviro.2015.06.003.
36. Tripathi S, Pohl MO, Zhou Y, Rodriguez-Frandsen A, Wang G, Stein DA, Moulton HM, DeJesus P, Che J, Mulder LC, Yanguez E, Andenmatten D, Pache L, Manicassamy B, Albrecht RA, Gonzalez MG, Nguyen Q, Brass A, Elledge S, White M, Shapira S, Hacohen N, Karlas A, Meyer TF, Shales M, Gatorano A, Johnson JR, Jang G, Johnson T, Verschueren E, Sanders D, Krogan N, Shaw M, Konig R, Stertz S, Garcia-Sastre A, Chanda SK. 2015. Meta- and orthogonal integration of influenza "omics" data defines a role for UBR4 in virus budding. Cell Host Microbe 18:723-735. http://dx.doi.org/10.1016/j.chom.2015.11.002.
37. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, Garcia-Sastre A. 2009. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5:439-449. http://dx.doi.org/10.1016/j .chom.2009.04.006.
38. Swedan S, Andrews J, Majumdar T, Musiyenko A, Barik S. 2011. Multiple functional domains and complexes of the two nonstructural proteins of human respiratory syncytial virus contribute to interferon suppression and cellular location. J Virol 85:10090-10100. http://dx.doi.org /10.1128/JVI.00413-11.
39. Meng J, Lee S, Hotard AL, Moore ML. 2014. Refining the balance of attenuation and immunogenicity of respiratory syncytial virus by targeted codon deoptimization of virulence genes. mBio 5:e01704 -14. http://dx .doi.org/10.1128/mBio.01704-14.
40. Wright PF, Karron RA, Madhi SA, Treanor JJ, King JC, O'Shea A, Ikizler MR, Zhu Y, Collins PL, Cutland C, Randolph VB, Deatly AM, Hackell JG, Gruber WC, Murphy BR. 2006. The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans. J Infect Dis 193:573-581. http://dx.doi.org/10.1086 /499600.